Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/16/25 21:00 | 7/15/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Adam S | NJ | DO | P,CEO | 6 | M.d | 1,480 | 13.71 | 0 | 108 | 3 | 3,774 | D | ||||||||||||||
7/16/25 21:00 | 7/15/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Adam S | NJ | DO | P,CEO | 6 | S.d | -1,480 | 13.71 | 0 | -108 | 3,774 | D | |||||||||||||||
6/16/25 21:00 | 6/12/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Elms Steve | NY | D | 2 | S.dm | -9,970 | 13.15 | 0 | -758 | 2,119 | M | ||||||||||||||||
6/16/25 21:00 | 6/13/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Elms Steve | NY | D | 2 | M.dm | 9,970 | 13.15 | 0 | 758 | 56 | 2,119 | M | |||||||||||||||
6/11/25 21:00 | 6/9/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Guiheen Lawrence P. | NJ | D | 3 | S.dm | -655 | 17.25 | 0 | -38 | 166 | D | ||||||||||||||||
6/10/25 21:00 | 6/9/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Jerrold B | NJ | D | 2 | M.d | 263 | 13.16 | 0 | 20 | 4 | 571 | D | |||||||||||||||
6/10/25 21:00 | 6/9/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Jerrold B | NJ | D | 2 | S.d | -263 | 13.16 | 0 | -20 | 571 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |